Literature DB >> 6995534

Immunoadsorbent affinity purification of the fifth component (C5) of human complement and development of a highly sensitive hemolytic assay.

R A Wetsel, M A Jones, W P Kolb.   

Abstract

The fifth component of complement (C5) has been isolated from human serum in fully hemolytically active form by immunoadsorbent and anion exchange column chromatography. The immunoadsorbent column was prepared by the covalent coupling of the purified IgG fraction obtained from monospecific goat anti-human C5 antiserum to CNBr activated Sepharose 4B. Establishment of appropriate conditions for the dissociation and elution of functionally active C5 from the immunoadsorbent column was of central importance in the development of this purification procedure. The C5 preparations exhibited final yields of 20--50% with 570--710-fold purification factors based on recovery of specific hemolytic activity. These preparations were free of contaminating serum proteins as judged by SDS-polyacrylamide slab gel electrophoretic and immunochemical criteria. A C5-depleted reagent (C5D) was generated from the non-adsorbed protein containing fractions obtained subsequent to the passage of freshly drawn NHS plus 10 mM EDTA through the monospecific anti-C5 Sepharose 4B column. Upon reconstitution of C5D with Ca2+, Mg2+, and C1q, this reagent was utilized for the detection and quantitation of C5 hemolytic activity. The purified C5 preparations contained 1.5--2.5 x 10(12) effective molecules/mg protein and NHS expressed 0.5--2.0 x 10(11) effective molecules/ml.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995534     DOI: 10.1016/0022-1759(80)90258-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes.

Authors:  P Xia; R E Jordon; W D Geoghegan
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

2.  Assembly of the functional membrane attack complex of human complement: formation of disulfide-linked C9 dimers.

Authors:  C F Ware; W P Kolb
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

3.  Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats.

Authors:  P J Baker; R F Ochi; M Schulze; R J Johnson; C Campbell; W G Couser
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

4.  Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement.

Authors:  E R Podack; J Tschopp
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

5.  Synthesis of complement component C5 by human B and T lymphoblastoid cell lines.

Authors:  W Reed; R A Roubey; J G Dalzell; B M Matteucci; B L Myones; S W Hunt; W P Kolb; G D Ross
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments.

Authors:  R A Wetsel; W P Kolb
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

7.  The rational design of affinity-attenuated OmCI for the purification of complement C5.

Authors:  Alex Macpherson; Xiaofeng Liu; Neesha Dedi; Jeffery Kennedy; Bruce Carrington; Oliver Durrant; Sam Heywood; Jean van den Elsen; Alastair D G Lawson
Journal:  J Biol Chem       Date:  2018-07-20       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.